Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01074554 · ClinicalTrials.gov registry record · Phase 1
Trial of Antimycobacterial Therapy in Sarcoidosis
A Phase 1 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01074554 is a Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 30 participants.
The verdict
NCT01074554, a Phase 1 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
Growing research from independent laboratories provide an association between mycobacteria and sarcoidosis. More recent immunologic and molecular studies demonstrate immune responses to mycobacteria virulence factors. The purpose of this study is to assess if administration of anti-mycobacterial drug therapy will aid in resolution of cutaneous sarcoidosis lesions.
Interventions
- DRUG Antibiotic Regimen
- DRUG Placebo Regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01074554
The ClinicalTrials.gov registry entry for NCT01074554 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Antibiotic Regimen is the first listed.
NCT01074554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01074554 about?
NCT01074554 is a clinical study titled "Trial of Antimycobacterial Therapy in Sarcoidosis". Growing research from independent laboratories provide an association between mycobacteria and sarcoidosis. More recent immunologic and molecular studies demonstrate immune responses to mycobacteria virulence factors. The purpose of this study is to assess if administration of anti-mycobacterial dru...
What is the current status of trial NCT01074554?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2010-02. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01074554?
The interventions under investigation include: Antibiotic Regimen (DRUG), Placebo Regimen (DRUG).
Who is sponsoring clinical trial NCT01074554?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.